Obesity Costs Fatten Health Care Spending
New research indicates that nearly 10 percent of all U.S. medical spending goes toward treating obesity and diseases more common in the overweight, such as diabetes and heart disease. Many health economists believe it is one of the leading causes of rising health care spending. About one-third of adult Americans are obese.
New research indicates that nearly 10 percent of all U.S. medical spending goes toward treating obesity and diseases more common in the overweight, such as diabetes and heart disease. Many health economists believe it is one of the leading causes of rising health care spending. About one-third of adult Americans are obese.
WAIT, BEFORE YOU GO…The New York Times:
Obesity’s not just dangerous, it’s expensive. New research shows medical spending averages $1,400 more a year for an obese person than for someone who’s normal weight.
Overall obesity-related health spending reaches $147 billion, double what it was nearly a decade ago, says the study published Monday by the journal Health Affairs.
The higher expense reflects the costs of treating diabetes, heart disease and other ailments far more common for the overweight, concluded the study by government scientists and the nonprofit research group RTI International.
If you're reading this, you probably already know that non-profit, independent journalism is under threat worldwide. Independent news sites are overshadowed by larger heavily funded mainstream media that inundate us with hype and noise that barely scratch the surface. We believe that our readers deserve to know the full story. Truthdig writers bravely dig beneath the headlines to give you thought-provoking, investigative reporting and analysis that tells you what’s really happening and who’s rolling up their sleeves to do something about it.
Like you, we believe a well-informed public that doesn’t have blind faith in the status quo can help change the world. Your contribution of as little as $5 monthly or $35 annually will make you a groundbreaking member and lays the foundation of our work.
By manufacturing in such poorly regulated countries as China and India, the industry risks that our drugs may be laced with carcinogens.
The presidential candidate travels with a caravan of type 1 diabetes patients seeking affordable insulin in America's northern neighbor.
“It felt like we were robbing the pharmacy,” one buyer says of the low prices she paid in Canada.
The Trump administration should veto the chemical giants' pending merger to protect not just competitors but human and environmental health.
"Less efficient" sleep might explain racial disparities in the risk for certain diseases, especially in women.
Frequent users of antibiotics were about 50 percent more likely to be diagnosed with Type 2 diabetes than those who had taken the drugs infrequently, researchers in Denmark found.
There are currently no responses to this article.
Be the first to respond.